CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK
42.10
17-May-24 15:59:59
15 minutes delayed
Stocks
-0.25
-0.59%
Today's range
42.09 - 42.38
ISIN
N/A
Source
NASDAQ
-
15 Dec 2022 18:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics to Present at Upcoming Investor Conferences
11 Nov 2022 06:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics Reports Third Quarter 2022 Financial Results and Business Updates
08 Nov 2022 06:30:00 By Nasdaq GlobeNewswire
-
19 Oct 2022 06:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
06 Sep 2022 06:30:00 By Nasdaq GlobeNewswire
-
12 Aug 2022 06:00:00 By Nasdaq GlobeNewswire
-
12 Aug 2022 06:00:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics Announces Proposed Public Offering of Common Stock
10 Aug 2022 16:01:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics Announces Proposed Private Offering of Convertible Senior Notes
10 Aug 2022 16:01:00 By Nasdaq GlobeNewswire
-
25 Jul 2022 17:00:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics Announces Updates to its Board of Directors
15 Jun 2022 06:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics to Present at the Jefferies Healthcare Conference
25 May 2022 06:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics Reports First Quarter 2022 Financial Results and Business Updates
10 May 2022 06:30:00 By Nasdaq GlobeNewswire
-
13 Apr 2022 06:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics Announces Upcoming Presentations at AAN 2022
31 Mar 2022 06:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics to Present at the Stifel 4th Annual CNS Day Event
21 Mar 2022 06:30:00 By Nasdaq GlobeNewswire
-
01 Mar 2022 06:30:00 By Nasdaq GlobeNewswire
-
16 Feb 2022 06:30:00 By Nasdaq GlobeNewswire
-
15 Feb 2022 06:30:00 By Nasdaq GlobeNewswire
-
10 Jan 2022 06:30:00 By Nasdaq GlobeNewswire